API	Active Pharmaceutical Ingredient
BGE	Background Electrolyte
β-CD	β-Cyclodextrin
CD	Cyclodextrin
CE	Capillary Electrophoresis
COSY	Correlation Spectroscopy
DIPE	Diisopropyl Ether
DIPEA	N,N-diisopropylethylamine
DMF	Dimethylformamide
DMSO	Dimethyl Sulfoxide
DoE	Design of Experiments
DS	Degree of Substitution
ee	Enantiomeric Excess
EMO	Enantiomer Migration Order
HMBC	Heteronuclear Multiple Bond Correlation
HOESY	Heteronuclear Overhauser Effect Spectroscopy
HPLC	High-Performance Liquid Chromatography
HP-β-CD	Hydroxypropyl-β-Cyclodextrin
HSQC	Heteronuclear Single Quantum Coherence
ICH	International Council for Harmonisation
IDE	Idelalisib
LOQ	Limit of Quantification
LOD	Limit of Detection
MeOH	Methanol
NMR	Nuclear Magnetic Resonance
NOESY	Nuclear Overhauser Effect Spectroscopy
pD	pH Measured in Deuterated Solvent
PI3Kδ	Phosphoinositide 3-Kinase Delta
R-IDE	R-Enantiomer of Idelalisib
ROESY	Rotating-frame Overhauser Effect Spectroscopy
Rs	Resolution
RSD	Relative Standard Deviation
S-IDE	S-Enantiomer of Idelalisib
TGA	Therapeutic Goods Administration
UV	Ultraviolet